Darby Kreienberg

Darby Kreienberg is a highly experienced Senior Research Associate with a strong background in various biotechnological and pharmaceutical research roles. Currently employed at Portal since June 2024, Darby previously held similar positions at Resonance Medicine, Inc., AvenCell, and TCR² Therapeutics Inc., where significant contributions included developing ELISA assays, optimizing CAR-T cell protocols, and utilizing CRISPR-Cas9 for gene editing. Academic experience includes research assistant roles at Northeastern University and Cleveland Clinic Lerner Research Institute, along with a strong foundation in biology from Case Western Reserve University and a master's degree in pharmacology from Northeastern University.